新生儿呼吸衰竭的体外膜肺氧合（ECMO）

Extracorporeal membrane oxygenation (ECMO) for neonatal respiratory failure.

作者信息

Zwischenberger J B, Cox C S

机构信息

Division of Cardiothoracic Surgery, University of Texas Medical Branch, Galveston.

出版信息

Thorac Cardiovasc Surg. 1992 Dec;40(6):316-22. doi: 10.1055/s-2007-1020172.

DOI:10.1055/s-2007-1020172

PMID:1290176

Abstract

Extracorporeal membrane oxygenation (ECMO) has been a successful treatment (82% survival) in over 5000 neonates with severe respiratory failure (80% predicted mortality without ECMO). ECMO is prolonged extracorporeal cardiopulmonary bypass achieved by extrathoracic vascular cannulation using a modified heart-lung machine. ECMO is currently the treatment of choice for full-term newborns with severe respiratory failure. The report summarizes indications, resulting complications, and future applications of neonatal ECMO.

摘要

体外膜肺氧合（ECMO）已成为5000多名患有严重呼吸衰竭的新生儿的成功治疗方法（存活率82%）（若无ECMO，预计死亡率为80%）。ECMO是通过使用改良心肺机经胸外血管插管实现的延长体外心肺转流。ECMO目前是患有严重呼吸衰竭的足月儿的首选治疗方法。本报告总结了新生儿ECMO的适应症、由此产生的并发症及未来应用。